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“You see, Momo,' he [Beppo Roadsweeper] told her one day, 'it's like this. Sometimes, when you've a very 
long street ahead of you, you think how terribly long it is and feel sure you'll never get it swept.' 
He gazed silently into space before continuing. 'And then you start to hurry,' he went on. 'You work faster 
and faster, and every time you look up there seems to be just as much left to sweep as before, and you try 
even harder, and you panic, and in the end you're out of breath and have to stop - and still the street stretches 
away in front of you. That's not the way to do it.' 
He pondered a while. Then he said, 'You must never think of the whole street at once, understand? You must 
only concentrate on the next step, the next breath, the next stroke of the broom, and the next, and the next. 
Nothing else.' 
Again he paused for thought before adding, 'That way you enjoy your work, which is important, because 
then you make a good job of it. And that's how it ought to be.' 
There was another long silence. At last he went on, 'And all at once, before you know it, you find you've 
swept the whole street clean, bit by bit. What's more, you aren't out of breath.' He nodded to himself. 'That's 
important, too,' he concluded.” 
            – Michael Ende 
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ABSTRACT 
The cell cycle is the process through which our cells grow and divide in a carefully orchestrated and 
controlled manner. An uncontrolled cell cycle is a basic hallmark of cancer, in which excessive cell 
growth leads to adverse effects on the tissue- and organ-level. The Ubiquitin Proteasome System (UPS) 
is responsible for the destruction of unwanted proteins in the cell, but has additionally been identified 
to inhabit regulatory roles in a myriad of cellular processes. This thesis aimed to study the cell cycle and 
the ubiquitin proteasome system using high-throughput and high-content approaches. 
The first approach aimed at observing the endogenous fluctuations of mRNA, proteins, 
phosphorylations, and intra-cellular compartmentalization over the cell cycle, and how these systems 
are regulated and coordinated throughout the cell cycle, described in Study I and II. Aside from 
characterizing cell cycle oscillation patterns of transcripts, proteins, phosphorylation events and 
subcellular localization changes, the dynamics between transcriptional and proteomic regulation was 
further investigated by comparing oscillation patterns of corresponding mRNA and protein pairs.  
The second approach aimed to investigate how one of the largest enzyme families in the human 
proteome, the UPS, affects the cell cycle and responses to external and intrinsic DNA damage. This was 
done through a phenotypical characterization after silencing the genes comprising the family in a high-
content imaging study, Study III. The results revealed many novel UPS genes as essential for proper 
progression through the cell cycle and maintenance of DNA integrity. By combining multiple reporter 
systems in one high-content study, correlations between cell cycle, viability and DNA Damage 
Response phenotypes could be performed. This revealed an increased tendency for G1/S-phase cell 
cycle arrests after signs of spontaneous DNA damage, and an enrichment for G2 cell cycle arrests after 
failure of 53bp1 recruitment to double-strand breaks.  
Aside from providing data resources and system biology results regarding the interaction between 
different cellular process, the studies also identified specific genes and proteins in novel roles regarding 
these basic cellular processes. In Study II, the methyl-transferase protein MAT2A was discovered to 
change subcellular localization in synchronization with the cell cycle, possible to provide the higher 
source of methyl groups needed during S-phase and G2-phase. In Study IV, the E3 ubiquitin ligases 
ARIH1 and ARIH2 were investigated for effects on proliferation and growth of glioblastoma 
multiforme. The high-content Study III identified many novel UPS genes with a myriad of cell cycle 
and DNA damage phenotypes, among them the E3 ubiquitin adapter BTBD1. Silencing of BTBD1 
incurred dramatic phenotypes on the cell cycle and DNA damage responses, and BTBD1 was further 
characterized and identified to be essential for proper function of the DNA topoisomerase TOP1.  
Throughout these projects, in order to validate novel findings, methods to control specific gene 
expression levels was developed, utilizing shRNA and CRISPR/Cas9-mediated silencing as well as a 
flexible method of overexpression. These systems are described in Study IV. 
The presented studies combine high-content and high-throughput approaches with novel visualization 
and analysis methods to distill information from complex data, both to summarize interactions between 
mRNA, proteins, and function, but also to identify novel regulators of basal cellular processes. 
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1 INTRODUCTION 
 
 
Figure 1. The Cell Cycle 
 
1.1 STUDYING THE CELL CYCLE 
The cell cycle is the regulatory system responsible for controlled replication and mitosis of 
cells, controlling proliferation. This proliferation is carefully orchestrated both during 
development and in the adult organism, and uncontrolled proliferation is a major hallmark of 
cancer. The broadest division of phases describes cells as going through the pre-replicative G1 
phase, through the Cyclin Dependent Kinase (CDK) regulated G1/S checkpoint into the 
replicative S-phase. After successful replication, the G2-phase leads past the G2/M-checkpoint 
into mitosis, the act of separating the chromatin followed by cytokinesis, cell division (Figure 
1). The CDK family of kinases has the most direct role on cell cycle events through the 
phosphorylation of effector proteins, especially to pass the cell cycle checkpoints. The 
activation of the CDKs is primarily controlled by the Cyclin proteins, as well as CDK inhibitory 
proteins (CKIs). The Cyclins oscillate over the cell cycle in a periodic fashion, giving rise to 
the precise events of CDK activation and subsequent activation of effector proteins (1,2). 
The most common way to study the cell cycle is to synchronize cells in a specific phase using 
inhibitor treatment, to then remove the inhibitors and follow the cells as they develop further 
(3). Thymidine-block and double-thymidine block are two common ways to achieve this. The 
first thymidine block arrests cells throughout S-phase, and if they are then released and 
thymidine-blocked again almost a cell cycle later, they exhibit a clear early S-phase blockade. 
G1G2
S
M
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To synchronize cells between G2 and mitosis, low concentrations of Nocadozole can be used. 
Other methods of synchronization are serum deprivation or contact inhibition, although this 
leads to many cells entering quiescence (4). A disadvantage with synchronization methods is 
that the synchronization itself deregulates the cell cycle and might cause more extreme mRNA 
depletions and enrichments than what would normally occur in freely dividing cells. Any 
chemical intervention also risks unwanted effects, which can be hard to separate from the 
studied biology. 
Contrary to synchronization, methods of separating asynchronous cell-cycle progressing cells 
have become of recent interest. Some methods use simple physics. The fact that mitotic cells 
are rounded up and loosely adherent in a cell culture flask can be utilized to collect them with 
a “mitotic shake off” (5). Cells additionally grow in size over the cell cycle, which can be 
utilized to separate enriched portions of cell cycle phases through centrifugal elutriation (3). 
 Other methods utilize genetic reporters. In 2008, an interesting method was developed for cell 
cycle studies by the Miyawaki group at the RIKEN Institute in Japan. They developed a set of 
fluorescent probes, using truncated peptides from hCdt1 and hGeminin coupled to different 
fluorescent proteins, to visualize the SCF/APC-complex activity equilibrium, closely following 
the regulatory cell cycle (6). During the S phase and G2-phase, the CDT1 probe is ubiquitinated 
and degraded together with its fluorescent protein by the APC-Complex using the effector 
protein CDH1, and at mitosis the Geminin probe is degraded by the SCF-complex with SKP2, 
leading to a clear distinction of cell cycle phases for use both in animal models and in vitro 
studies, including live-cell imaging, flow cytometry or high-throughput imaging studies (6–9).  
Two major studies in recent years have performed transcriptome-wide characterizations of cell 
cycle expression of proteins. The first one, by Whitfield et al, used a MicroArray-based 
approach to characterize transcripts from cells released from synchronization with time-points 
covering three full cell cycle phases (10). They then fitted sinus curve expression patterns to 
these as a statistical test. The second study was conducted by Dominguez et al. (2016), who 
used a smaller amount of time-points and a seed-matching approach to identify oscillating 
genes (11). 
Although transcriptional regulation of protein-coding genes is a major driver of proteomic 
regulation, many other processes are involved in regulation of protein levels. When studying 
cell types and tissues, transcriptomics and proteomics can correlate (12) but mRNA is not 
always a reliable indicator of protein changes (13). Especially when studies include a temporal 
aspect, delays between mRNA and protein can combine with other regulatory mechanism to 
create a more complex relationship (14). Other processes affecting protein dynamics include 
the inherent stability of proteins, and degradation through the Ubiquitin Proteasome System 
(UPS), which can also be used by the cell to actively regulate protein availability. The actual 
function of a protein is additionally not only dependent on protein levels, but can also be 
affected by post-translational modifications (PTMs), such as phosphorylation or regulatory 
ubiquitin-chains, or through subcellular localization (15).  
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Proteome-wide studies of the cell cycle have previously been performed on asynchronous cells 
by Lamond and colleagues, separating cell cycle phases using centrifugal elutriation (16) or 
separation of via a combination of DAPI and phospho-histone-H3 on fixated cells (17). Other 
high-throughput protein studies on the cell cycle utilizing synchronization methods have 
studied mitotic phosphorylation patterns (18,19) protein stability (20) and protein interactions 
(21). 
1.2 THE UBIQUITIN PROTEASOME SYSTEM 
The conjugation of ubiquitin, while primarily used as a degradation signal in the UPS, has been 
found to signal a broad variety of regulatory functions and has been implicated to play a role 
in a wide variety of diseases. Its major role, using the classical ubiquitin conjugation machinery, 
is to direct the activity of the proteasome system and regulate protein degradation. The 
complexity of different chain linkages, branching of ubiquitin chains, and ubiquitin-like 
proteins shows that the system is involved in many more types of regulatory control.  
The conjugation machinery involved in ubiquitination consists of various subfamilies. The E1 
ubiquitin-activating enzymes, the E2 ubiquitin conjugating enzymes and E3 ubiquitin ligases 
work together to conjugate ubiquitin with targeted proteins, while the deubiquitylating proteins 
(DUBs) facilitate deconjugation of ubiquitin, both as a regulatory mechanism but also to 
recycle ubiquitin from the proteasome (22) (Figure 2). 
 
 
Figure 2. The Ubiquitin Proteasome System 
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The small protein Ubiquitin was first identified in 1975, and received its name from its 
ubiquitous expression in all tissues. In 2004, the discovery of ubiquitin-mediated degradation 
was awarded the Nobel Prize in Chemistry (22). After its initial discovery, a multitude of 
functions and regulation of processes have been attributed to the system. The multitude of 
genes dedicated to the UPS system, over 4% of all known genes in the human genome, 
indicates its extensive use as a regulatory system, not only limited to housekeeping functions. 
Four genes produce the ubiquitin protein, UBA52, RPS27A (ribosomal protein-conjugated 
monoubiquitin), UBC and UBD (linear polyubiquitin). A number of Ubiquitin-Like Proteins 
(UBLs) have been identified, in size and structure similar to ubiquitin but not responsible for 
degradation. These UBLs have various roles, for example ISG15 is activated by interferon 
signaling and conjugates various substrates in immune control (23). The Small Ubiquitin-Like 
Modifier (SUMO) family of UBLs is comprised of four paralog genes, and involves a number 
of E1s, E2s and E3s. Sumoylation does not lead directly to degradation, but has been found to 
play a role in cell cycle control, localization signaling and indirect protein stability regulation 
through recruiting E3 ligases (24).  
The E1 and E2 enzyme families are relatively small, with nine recognized E1 enzymes and 
around 40 E2 enzymes. The role of the E1 ubiquitin-activating enzymes is to form a covalent 
thiol-ester bond with ubiquitin, priming it for transfer. The ubiquitin is then transferred to the 
E2 conjugating enzyme which, in a concerted reaction with the E3 ligase, conjugates it to the 
substrate. Most substrate specificity is thought to lie in the E3 family, with many E3 enzymes 
lacking enzymatic activity acting instead as adapter proteins or substrate recognition proteins. 
Over 600 E3 Ligases have been recognized (22).   
The three major groups of E3 families are the RING-(Really Interesting New Gene)-Finger-
Proteins (RNFs), the U-Box-containing proteins, and the HECT (Homologous to the E6AP 
Carboxyl Terminus) Family of proteins. The RING-, HECT-, and U-Box domains are 
responsible for binding to their corresponding E2 protein, and the other domains have substrate 
specificity, enzymatic and other adapter functions. While most HECT-family proteins have 
ligase activity, most RNF proteins only act as adapters or substrate-recognition factors (25).  
A common complex form of E3 activity is the Cullin-Ring-Finger (CRL) complex, which 
contains specialized E3 proteins as adapters, substrate recognition factors and effectors. The 
most well-known type of CRL complex is the group of Skp1-Cullin1-F-Box (SCF) complexes 
involved in cell cycle regulation (26). 
The E3 Ubiquitin adapter BTBD1 belonging to the CRL3 complex was identified in 2001, 
together with BTBD2 as a novel family of genes containing the BTB-Domain The BTB-
Domain is found to be evolutionary conserved in many species, not only on ubiquitin-related 
genes. It is thought to facilitate homo-dimerization, and is usually accompanied by a Kelch-
domain and/or a zinc-finger-domain, neither of which were found in BTBD1 or BTBD2 (27). 
A specialized form of CRL complexes have been identified, called CRL3, combining Cullin3, 
Rbx1, and a BTB-domain-containing protein (26). The BTB-domain is evolutionary conserved 
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and was first found in Drosophila melanogaster. Known BTB-domain-containing proteins 
belong to the KBTBD- and KLHL-families (28), but potentially BTBD1 also could be part of 
the CRL3-complex; affinity-mass-spectrometry experiments suggest a high interaction 
between BTBD1 and Cullin3 (29). 
It has additionally been found that BTBD1 interacts with Topoisomerase-1 (TOP1) (30) and 
that silencing of BTBD1 induces caspase 3 and caspase 7 activity (31). 
An additional family with only two members, the E4 ubiquitin ligases has been found to 
facilitate multi-ubiquitin assembly and editing (32). 
The primary ubiquitination event is usually mono-ubiquitination which enables poly-
ubiquitination and the creation of chains. The ubiquitination takes place through a conjugation 
of the C-terminal peptide of ubiquitin and a lysine peptide on the target substrate. Ubiquitin 
itself has seven different lysine (K) residues (K6, K11, K27, K29, K33, K48, and K63), and 
the lysine used in further poly-ubiquitination confers various signals (Figure 3). The K48 
lysine chain signals for transport to the proteasome and degradation, while the K63 chain 
linkage is involved in trafficking and cellular signaling processes (22). Other chains have more 
recently been investigated, and many of their roles are not entirely elucidated (33). K11 chain 
linkages are known to be utilized as a degradation signal in mitotic exit by the APC complex 
(34,35) and K27 chain linkages has been implicated in RNF168-mediated ubiquitination of 
chromatin at DNA damage sites (36).  
 
               
Figure 3. Ubiquitin Chain Linkages 
 
The family of deubiquitylating enzymes is a subfamily of ubiquitin proteins responsible for 
hydrolyzing the ubiquitin group or ubiquitin-like proteins (UBLs) from target proteins. This 
family comprises around 100 proteins in five subfamilies, with the largest subfamily being the 
Ubiquitin-Specific Proteases (USPs) that deconjugates bound ubiquitin (37). The other cysteine 
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protease families are the Ubiquitin-Carboxyl-terminal Hydrolase (UCH) family, the Machado-
Joseph disease protein domain (MJD) proteases, and the Ovarian Tumor protease (OTU) 
family. In addition, there is a family of metalloproteases, the MPN+/JAMM family, that 
employs a zinc ion for proteolytic cleavage (38). Other notable subfamilies include the 
SUMO/Sentrin-specific (SENP) proteases, which deconjugate the SUMO UBLs. Ulp1 and 
Ulp2 also perform this function, although they were not originally classified as SENPs. An 
exception is SENP8 which has been found to be responsible for NEDD8 (a Ubl) deconjugation 
(24). 
Deconjugation is used by the cells not only to recycle ubiquitin at the proteasome but also to 
achieve regulatory control over protein turnover. The balance between the conjugation and the 
deconjugation machinery can be under fine control, allowing cells to achieve quick changes in 
protein amounts via ubiquitin system regulation.  
Different ubiquitin system pathways have been proposed as therapeutic drug targets in a 
number of diseases. In many cases of neurodegenerative diseases, such as Parkinson’s disease, 
Alzheimer´s disease and Huntington’s disease, part of the disease profile is the accumulation 
of plaques of proteins. This could be explained by a dysregulation of the UPS system, which 
makes it a possible target for therapeutic intervention (39). 
In cancer biology, the most studied example of the ubiquitin system is the interaction of 
MDM2, an E3 ligase, and p53 a tumor suppressor. p53 is constantly degraded by the UPS 
system until signaling changes the balance. Cancer cells need to deregulate this balance, either 
by functionally inactivating p53 itself or by overexpression of the MDM2 protein (40). This 
makes this balance an interesting therapeutic target in non-p53-inactivated cancers.  
Another therapeutic strategy exploiting the ubiquitin-proteasome system focuses on the class 
of proteasome inhibitors. Since cancer cells proliferate more frequently and can utilize 
degradation pathways to inhibit tumor suppressors and apoptotic signaling, proteasome 
inhibitors have performed well in preclinical and clinical trials. The most successful one so far 
is a proteasome inhibitor called Bortezomib (Velcade®) (41), targeting the chymotrypsin-like 
region of the 26S proteasome. Over 200 clinical trials have been performed so far with 
Bortezomib, and many similar compounds with varying efficacies have been developed (41).  
A recent targeting strategy aimed at inhibiting the proteasome is the use of VLX1570 from the 
Linder Group at Karolinska Institutet. VLX1570 is an analogue of their earlier deubiquitinase 
inhibitor b-AP15 that claim to target the two proteasome-associated deubiquitinases UCHL5 
and USP14 (42). The role of UCHL5 and USP14 is to remove ubiquitin itself from the 
proteasome in order to recycle it back into circulation. VLX1570 is developed as a more potent 
USP14-specific inhibitor and is currently in clinical trials (43). 
1.2.1 Ubiquitome-Wide Studies 
In recent years, a number of large-scale projects have been published describing aspects of the 
ubiquitin-machinery using different approaches. In 2009, the Wade-Harper lab published a 
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paper describing a high-throughput immunoprecipitation/mass-spectrometry approach to 
characterize the targets and associated proteins of the deubiquitylating family of enzymes (44). 
They have since, together with the Gygi laboratory, developed a proteomic approach to identify 
ubiquitination sites using mass spectrometry to identify “diGly remnants”, and performed these 
experiments with and without the use of proteasome inhibitors to differ between degradation 
and regulatory signals (45) or a NEDD8 modification since NEDD8 leaves a diGly remnants 
on the peptides.  
More recently, in 2017, a study by the Vermeaulen group published a paper describing the 
interaction landscape to ubiquitin chains using uncleavable diubiquitin probes for all the 
specific chains, and characterizing interactors in three cell types: HeLa cancer cells, embryonic 
stem cells, and neuronal precursor cells (46). 
1.2.2 The Ubiquitin System in DNA Damage Response Pathways 
Maintaining DNA integrity is essential for cellular proliferation, and the cell has a multifaceted 
and highly redundant response machinery to respond to DNA damage (47). The response 
depends primarily on the specific kind of DNA damage, be it single- or double-strand breaks, 
bulky adducts or other lesions, but the response can also be affected by the state of the cell.  
Common inducers of DNA damage are reactive oxygen species, UV-induced damage from 
sunlight, genotoxic chemicals and ionizing irradiation. The DNA damage types are multiple; 
mismatching base pairs, adducts and single-strand or double-strand breaks. As genomic 
integrity is crucial, especially for dividing cells, the cell employs a variety of strategies to 
identify and deal with DNA lesions (48). In dividing cells, the DNA damage response (DDR) 
also influences the cell cycle, by halting the cell at the most appropriate checkpoint (49). The 
UPS has been implicated to be involved in many DDR pathways and processes, both in a 
degradation capacity but also through regulatory functions (50–53).  
PCNA is a major enzyme in control of DNA replication and DNA repair control and 
recruitment. It is a trimeric protein encircling the DNA strand and is essential for replication 
activation. In replication, PCNA is sumoylated by Siz1/UBE2I. After DNA damage occurs, 
PCNA is activated by mono-ubiquitination by RAD18 to promote translesion synthesis (TLS). 
To turn off this process, mono-ubiquitylated PCNA is targeted for ISG15-ylation, which then 
recruits the deubiquitylating enzyme USP10 which removes the mono-ubiquitin. The ISG15 
protein is later cleaved off for reuse by USP18 (54). More recently, ISG15 has also been shown 
to be induced upon various sources of DNA damage (55). 
The cell-cycle dependent availability of genetic material can affect the process utilized to repair 
specific sites, such as the balance between homologous recombination (HR) (56) and non-
homologous end-joining (NHEJ) (57) in response to DNA double strand breaks (DSBs) (58–
60). NHEJ repairs DSBs through direction ligation, while HR repairs the damaged site through 
recombination with a homologous segment of DNA, often a sister chromatid. The processes of 
HR and NHEJ inhibit each other, and the initiation and recruitment of either is part of a complex 
machinery. 
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At double-strand breaks, complexes recognizing DNA lesions recruit the ATM Kinase which 
phosphorylates H2AX. γ-H2AX then recruits various other proteins, among them the E3 Ligase 
RNF8, which, together with the E2 conjugase UBE2N and RNF168 polyubiquitinates the 
histone (61–63). This ubiquitination is of the K63-chain variety and has no degradation effect, 
but recruits 53BP1 and BRCA1, two major players in double-strand break control (63). 
Another histone modification necessary for 53BP1 recruitment is methylation at H4-K20 
which is proposed to be mediated by PCNA (64) but this is still under debate. BRCA1 primarily 
promotes homologous recombination to repair the double-strand break while 53BP1 promotes 
non-homologous end-joining. BRCA1 uses the E3 ligase UHRF1 to signal for degradation of 
RIF1, an essential cofactor to 53BP1. This is performed in S-phase when the cell preferentially 
wants to repair double-strand breaks using homologous recombination (65). Sumoylation also 
performs multiple roles during double-strand break repair, including the de-sumoylation of 
KAP1 to release CDH3 in order to relax the chromatin. BRCA1 has also been found to be 
regulated positively through direct sumoylation (66). The deubiquitinating enzyme OTUB1 
has been identified to inhibit RNF168-mediated poly-ubiquitination at DSB sites, through 
interacting with UBE2N, the E2 conjugase affiliated with RNF168 (67). Another 
deubiquitinating enzyme, USP1, is involved in the repair choice at DSBs, and it has been shown 
both to remove K63-ubqiquitin chains from histones at the control of the APC-complex (60), 
and through deubiquitinating of PCNA together with UAF1 (68).  
1.2.3 The Ubiquitin System in Cell Cycle Control 
The control of the turnover of the cyclins as well as CKIs is performed by the ubiquitin-
proteasome system. Two major ubiquitin system complexes regulate cell cycle control, the 
SKP1-CUL1-F-Box-(SCF)-complex and the anaphase-promoting complex/cyclosome 
(APC/C) (69,70). In the SCF complex, the F-box proteins confer substrate specificity and are 
variable; currently around 70 have been found. The most important F-box proteins in cell cycle 
control are SKP2, FBXW7 and β-TRCP (FBXW1) (71,72). SKP2 is a common oncogene in 
cancer development, as an overexpression of it leads to decreased stability of the CKI and 
tumor suppressor p27 (CDKN1B). In normal cell cycle progression, SKP2 acts in S-phase and 
G2-phase to destabilize negative regulators of cell cycle progression (73). FBXW7 on the other 
hand is a negative regulator of the cell cycle and has been found to be deactivated through 
mutation in many cancers. β-TRCP is a versatile protein which has been found to regulate 
stability of both cell cycle drivers and negative regulators, and has been seen to be both 
overexpressed and mutated in cancers (71). 
The APC complex is composed of 13 invariable components, the APC proteins, as well as an 
effector protein. The effector proteins of the APC-complex are also variable, with two of the 
most important proteins being CDC20 and CDH1, which act to promote sister chromatid 
separation and mitotic division. The APC-complex stays upregulated during G1-phase to 
negatively regulate mitotic cyclins (71). The Fucci System utilized in this thesis utilizes 
degradation sites recognized by the SCF- and APC-complex respectively in order to act as a 
reporter of cell cycle progression (6). 
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1.3 THESIS RATIONALE 
The Ubiquitin Proteasome System and the Cell Cycle are two major regulatory systems that 
have been studied for decades. They are complex in both the sheer number of proteins involved, 
but also due to interaction between the systems and other cellular processes. This complexity 
suggests there is still a lot to be discovered and that novel approaches not only in data 
acquisition methods such as mass spectrometry, RNA sequencing and high content imaging, 
but also in analysis methods, needs to be employed to unravel the intricacies of these regulatory 
systems. As high-throughput and high-content methods are getting more advanced and more 
accessible to the scientific community, I believe the integration of results from modern 
methodologies will provide additional insights into these basic cellular processes. 
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2 THESIS AIMS 
The cell cycle and the UPS are two highly studied biological systems with well-known 
regulators. As the advent of modern high-throughput and high-content methodologies have 
enabled new systems biology approaches to study biological processes, it has also introduced 
challenges and opportunities in comparative data analysis.  
The central aim of this thesis is to study how the cell cycle affects gene expression, protein 
availability, and protein function, and how the ubiquitin proteasome system is involved in this 
essential cellular process, while developing novel methods of visualizing and analyzing high-
throughput and high-content data. 
Specific Project Aims: 
Project I: To characterize gene expression profiles throughout the cell cycle, and introduce 
novel analysis methods to investigate family-wise patterns of oscillation with a focus on 
transcription factor control.  
Project II: To characterize the proteome, the phospho-proteome, and the subcellular proteome 
over the cell cycle, and investigate the interplay between different cell-cycle regulated systems 
using novel visualization and analysis methods. 
Project III: To characterize the effect of the individual genes in the ubiquitin proteasome 
system on cell viability, DNA repair pathways and cell cycle control, and the interaction 
between them, in order to identify novel mechanisms. 
Project IV: To develop a highly adaptable vector system for genetic manipulation using 
shRNA, overexpression and CRISPR/Cas9, a toolbox enabling flexible in-house high-
throughput and targeted research. 
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3 METHODOLOGICAL APPROACHES 
3.1 BIOLOGICAL MODELS  
3.1.1 Cell Line Models 
Throughout the studies, various cell line models were utilized, both unmodified but also 
integrated with genetic modifications, either to modify the expression of specific genes or to 
provide reporter system functionalities. For Study I and II, the cervical cancer cell line HeLa 
(74) and the osteosarcoma cell line U2OS (75) was utilized, both genetically modified with the 
Fucci cell cycle reporter system (6). In Study III, Fucci U2OS cells (kind gift from Dr. Masai 
at the Tokyo Metropolitan Institute of Medical Science, Japan) were utilized in siRNA 
characterization studies, and were also stably integrated with an inducible shRNA expression 
system targeting a multitude of genes. In Study IV, stable shRNA Fucci U2OS cell lines were 
utilized, as well as multiple glioblastoma multiforme cell lines; U87MG (ATCC), M059K, 
GBM-H18, U343MG (kind gift from Prof. Monica Nister, Karolinska Institutet), as well as 
GBM stem cell lines U3013 and U3047 (obtained from HGCC, Uppsala University).   
3.1.2 Orthotopic Zebrafish Model 
An orthotopic model of glioblastoma multiforme growth in zebrafish hindbrain was utilized 
in Study IV to validate the use of multi-fluorescent viability experiments, using four U87MG 
GBM cell lines expressing four different fluorescent reporters co-expressed with four unique 
shRNAs. The orthotopic model was performed as developed by Pudelko et al (76). 
3.1.3 Cell Cycle Reporter Systems 
The Fucci System consists of two peptides of hCDT1 and hGeminin that are targeted and 
degraded by the cell-cycle oscillating complexes SCF and APC. The peptides are truncated and 
limited to the peptide sequence recognized by the APC and SCF-complex. The truncated 
peptides are conjugated to two fluorescent markers, originally mKO2 and mAG (6), which 
enables cell cycle classification and separation without any need for fixation or addition of 
chemicals. The Fucci reporter system integrated into our down-regulatory plasmid system 
utilizes the green fluorescent protein Clover instead of mAG (77). 
3.1.4 Methods of Gene Silencing and Expression 
Throughout the present studies, various methods of modifying gene expression were utilized. 
siRNA libraries were used in order to characterize a large number of gene silencing phenotypes 
on cell lines in Study III, and to further validate some of these findings, stable integrated 
tetracycline-inducible shRNA constructs were inserted lentivirally into the genetic sequence of 
various cell lines in Study III and Study IV (78). CRISPR/Cas9 functionality was additionally 
integrated in the plasmid system developed in Study IV. 
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3.1.5 Plasmid Development 
Through the studies a suite of plasmids was created, both for overexpression of tagged 
exogenous genes, and to silence genes through shRNA or CRISPR/CAS9. Many different 
methodologies were utilized for creation and modification of genetic vectors, such as 
subcloning of PCR-amplified genetic fragments, subcloning from synthesized genetic 
sequences, or ligation of annealed oligonucleotides. For overexpression purposes, plasmids 
were separated into pENTR and pDEST plasmids, with Gateway Cloning (79,80) utilized to 
move sequences into lentiviral-compatible vectors for use in cell experiments. As all silencing 
vectors and pDEST vectors contained repetitive elements, recombination-deficient Stbl3 
Escherichia coli cells were used to amplify these vectors. For isolation and amplification of 
pDEST vectors containing the toxic ccdb-region, ccdb-resistant E. coli cells were used. The 
plasmids were created with a modular design philosophy, to enhance flexibility and ease of 
use. Study IV describes in detail the specific molecular biology procedures utilized for the 
plasmid systems used throughout the studies comprising this thesis. 
The plasmid systems utilized a collection of fluorescent proteins (FPs), distributed along the 
visual spectra (81). The field of FPs have progressed far since the initial discovery of GFP (82), 
and directed and random mutagenesis has produced FPs with different spectral properties, 
many of which are available in our system (6,77,83–88), as well as two different luminescence 
reporters (89,90). For acquiring comparable data of FPs for visualization and comparison, the 
FPBase online database proved useful (91).  
3.2 DATA ACQUISITION  
3.2.1 Cell Biology Techniques and Phenotypical Characterizations 
This section summarizes essential assays and experimental techniques utilized throughout the 
thesis in characterization of cellular processes, both observationally without intervention, but 
also after external regulation of genes and proteins or chemical intervention.  
3.2.1.1 Viability Assays 
Throughout the studies, various methods of measuring cellular viability and proliferation were 
employed, from plate-measurements, colony-formation assays and counting individual cells. 
Resazurin viability assays measures cellular viability in an entire well through measuring the 
color change of Resazurin in response to aerobic respiration (92). A Trypan Blue colony-
formation assay was used to verify effects on cellular viability in inducible shRNA cell lines 
in Study III. The highest resolution of cellular viability, the exact count of cells was achieved 
via two methods, through flow cytometry in Study IV and through automated counting of 
segmented DAPI-stained nuclei in microscopic images in Study III.  
3.2.1.2 Cell Cycle Characterization Methodologies 
To characterize the cell cycle distribution in a population of cells, two distinct methods were 
utilized through Study III and IV. Categorization using the Fucci system was performed by 
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quantifying the expression of mKO2 and mAG fluorescent proteins, and categorizing each cell 
as either single-positive for one (G1- and G2/M-phase respectively) or double-positive (S-
phase). This was performed either by using flow cytometry and through automated 
classification of high-throughput microscopic images (Figure 4). 
As the Fucci system is a reporter of the cell’s regulatory cell cycle progress, the state of the 
DNA is a reporter of the mitotic cell cycle. We utilized a combination of DAPI quantification 
and quantification of replication-integrated EdU on microscopic images to accurately 
categorize cells on events regarding DNA content and replication status. When DAPI staining 
was utilized for chromatin quantification, it was always preceded by an hour-long incubation 
with RNAse I and PBS-washes, in order to remove possibilities of intercalation of DAPI to 
RNA. EdU is a thymidine analog which contains a free alkyne group, allowing for click-
chemistry-based conjugations of azide-conjugated fluorophores post-fixation (93–95).  
 
 
Figure 4. Example fluorescence images of Fucci, DAPI, EdU and 53BP1 foci 
 
3.2.1.3 DNA Integrity, Damage and Response Assessments 
In order to characterize cellular phenotypes related to DNA integrity and the DDR, multiple 
methods were utilized.  
To investigate DNA replication speeds, a fiber assay was utilized in Study III, wherein cells 
were incubated with two sequential nucleotide analogs (CIdU and IdU), and single molecule 
DNA fiber lengths were measured using fluorescence-conjugated secondary antibodies. The 
distribution of fiber lengths corresponds to the distribution of replication capacity with the 
nucleus.   
To investigate DNA integrity in Study IV, a Single Cell Gel Electrophoresis (COMET) assay 
was used, wherein low melting agarose encapsulates the cells followed by electrophoresis. 
Fragmented DNA then travels further and creates the titular comet tails which lengths are 
measured and compared to the nuclei. 
Antibodies against DDR proteins were also utilized, both using western blotting but also using 
immunofluorescence techniques. Using immunofluorescence, foci formation patterns of the 
DSB-recruited enzymes BRCA1 and 53BP1 could be counted as an indicator of the cellular 
Fucci Distribution DAPI Quantification EdU Integration 53BP1 foci
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response to DSBs, and the choice between homologous recombination and non-homologous 
end-joining. Integrated intensities of the two proteins was also measured to control for 
availability. 
3.2.1.4 Interaction studies 
Two methods were used to investigate protein-protein or protein-DNA interaction. Proximity 
Ligation Assay (PLA) was used to verify the interaction between the E3 Ubiquitin Adapter 
BTBD1 and TOP1 in Study III. PLA works by conjugation of two complementary 
oligonucleotides to two secondary antibodies, and an in-cell amplification and binding of a 
fluorescent reporter when these two oligonucleotides are co-localized. Another method of 
protein interaction, chromatin immunoprecipitation (ChIP), was used to characterize the 
BTBD1-silenced-mediated binding of TOP1 to transcription start sites of the genome.  
3.2.1.5 High Content Imaging-Specific Methodologies 
For performing high-content imaging experiments in Study III, various liquid distribution and 
plate handling equipment were utilized. For initial siRNA library generation, siRNAs targeting 
UPS genes were collected from a genome-wide library using an Echo Liquid Handler. For 
plating of cells, reagents, and washes in 384-well plates, an 8-tube peristaltic MultiDrop 
dispenser was utilized. Images were acquired on an Operetta HighContent Imaging System 
(PerkinElmer) and an ImageXpress HighContent Microscope (Molecular Devices), connected 
to robotic plate handlers (Thermo). Image analyses was performed through batch processing at 
the UPPMAX data cluster, and output data stored in a SQL database. Data analysis was 
performed in the software R (96) using the dplyr package (97) and figures were prepared with 
the ggplot2 package (98). 
3.2.2 Transcriptomics, Proteomics, and Phospho-Proteomics 
Transcriptomics and proteomics approaches were used primarily in Study I and II on Fucci 
cells sorted by flow cytometry in order to objectively study the cell cycle oscillations of mRNA 
and proteins. In Study I we utilized transcriptomic analysis to detect mRNA expression 
patterns over the cell cycle in two cell lines, U2OS and HeLa. In Study II, cell-cycle oscillating 
proteins were investigated, and phospho-proteomics were used to additionally characterize 
cell-cycle dependent phosphorylation events. In Study III, mass spectrometry was utilized to 
investigate proteomic changes after shRNA-mediated BTBD1 silencing. Cellular material was 
labeled using an isobaric mass tag TMT10plex method (99), and a TiO2 phosphopeptide 
enrichment method was used prior to phospho-proteomic mass spectrometry. Proteomic 
Analysis was performed with the softwares MaxQuant (100), Andromeda (101), Perseus (102), 
and R (96). Raw data from transcriptomic experiments was submitted to the NCBI GEO 
repository (103) and raw proteomic data was deposited at the PRIDE repository (104). 
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3.3 DATA ANALYSIS 
3.3.1 High Content Imaging Data Analysis  
For all analysis of immunofluorescent images, the software CellProfiler was used (105,106). 
CellProfiler contains a library of image analysis algorithms, from image organization, image 
normalization, segmentation and feature extractions. After feature extraction, categorization of 
cells and summarization of results was performed in R, starting with the per-object output files 
from CellProfiler. The process from acquired images to analysis of data is summarized in 
Figure 5. 
Choice of features to utilize for each fluorescent marker was chosen according to the 
mechanism and function of each marker or reporter. For DAPI quantification, where the aim 
was to quantify the cellular content of DNA, integrated intensities were used.  
Normalization was performed either before feature extraction to remove variable background 
noise arising from optical effects and uneven backgrounds, or in R on the extracted feature 
descriptors, where negative control wells spread throughout the plates were used to correct for 
batch-wise, inter-plate, or intra-plate variations. 
 
 
Figure 5. High Content Image Analysis Pipeline 
 
3.3.2 Comparison of Tri-Group Relative Data Utilizing a Polar Coordinate 
System 
To visualize and compare cell cycle oscillation patterns an algorithm was developed, called 
TriComp. It utilizes a polar coordinate system to plot the relationship between a quantitative 
variable measured in three groups, while ignoring the average value. This enables a structured 
approach of plotting the thousands of data-points generated from transcriptomic or proteomic 
experiments. The radius corresponds to the logarithmic fold change difference between the 
three groups, and the degree angle corresponds to the specific relationship between the three 
groups. The triangularization equations and pedagogical examples of how the algorithm 
functions is summarized in Suppl Figure 1 of Study II.  
Segmentation
For each
Feature
Categorization Summarisation
Per Well Per Condition
Feature Extraction Normalization(feature data)
Normalization
(image data)
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3.3.3 Comparison of Tri-Group Distribution Data Utilizing a Triangular 
Coordinate System 
To visualize and compare cell cycle distribution patterns in Study III, another algorithm was 
developed. The algorithm produces coordinate values in a triangular coordinate system, 
where each point corresponds to a distribution of three groups, summing up to 100%. An 
imagined line perpendicular to each side of the triangle directly corresponds to the percentage 
of each of the three cell cycle phases.  
3.3.4 Statistical Analyses 
In Study I, in order to calculate statistically significant oscillations of transcripts over the cell 
cycle, a Generalized Linear Model using a negative binomial model was used, from the R 
package edgeR (107). Similarly, in Study II, to calculate p-values of statistical significance on 
proteomic and phospho-proteomic results, Analysis of Variance (ANOVA) was performed for 
each unique protein or phosphopeptide.  
Additionally, throughout the studies, different enrichment analyses were performed. When 
comparing a distribution of factors to an encompassing parental distribution, log-likelihood 
ratios were computed using the XNomial package in R (108). When comparing separate 
distributions, fisher tests were performed in R, with higher values using a Monte Carlo 
simulation. 
Gene Ontology enrichment analyses was performed in Study I and II. When comparing a set 
of genes or proteins to Gene Ontology gene sets (109,110), the online resource DAVID 
Functional Annotation Tool was utilized (111,112). When comparing gene lists to individual 
gene sets, such as the cell-cycle-specific GO-terms in Study I, this was performed in R or 
Microsoft Excel. In Study II for identifying enriched kinase motifs, the motif prediction tool in 
Perseus (102) was used.  
When comparing normally distributed quantitative values of two groups, Student’s T-tests 
were utilized.  
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4 RESULTS 
4.1 CHARACTERIZING CELL CYCLE OSCILLATIONS OF MRNA, PROTEINS, 
AND PROTEIN FUNCTION. 
In Study I, we characterized the cell cycle oscillating transcriptome in unsynchronized cells. 
Aside from confirming major cell cycle regulatory pathways to be transcriptionally regulated, 
both through known examples and through GO-term enrichment analysis, we could also show 
the inherent link between the circadian rhythm and the cell cycle.  
In order to visualize and categorize cell-cycle oscillating transcripts, we developed a novel 
algorithm using a polar coordinate system: TriComp. For a TriComp graph, the radius (r) 
corresponds to the intensity of the cell cycle oscillation, and the angle (θ) corresponds to the 
type of relationship between the three groups. In the TriComp comparison graphs, a subsequent 
pattern does not necessarily mean a later expression peak, as the results focus on the 
relationship between the three groups, and not which individual phase has the maximum 
expression. A basic subdivision of the relationships was used to divide all hits into G1-, G1+S-
, S-, S+G2-, G2-, or G1+G2-upregulated.  
Overall, the majority of cell-cycle oscillating transcripts were either moderate level G1+S-
specific or high level G2-specific. Stratifying the data on transcription factors revealed an 
overall similar patterns for most TF families. An interesting exception was the E2F family of 
transcription factors, which were all upregulated in S-phase, either alone or with a 
corresponding upregulation in G1-phase or G2-phase. We investigated known targets of the 
E2F1 transcription factor, and saw a highly significant corresponding pattern of E2F1-targets, 
compartmentalized between G1+S- and S+G2-expresstion patterns. Comparing U2OS and 
HeLa cells show a conserved pattern of cell cycle transcriptional regulation, with very few hits 
having different cell-cycle enrichment phases, but an investigation of U2OS- and HeLa-
specific oscillating transcription factors and a GO-term enrichment analysis revealed these to 
be enriched for different GO-terms involved in differentiation and developmental programs.   
In Study II we used the biological model and the TriComp algorithm from Study I to 
characterize the cell-cycle dependent behavior of the proteome and phospho-proteome over the 
cell cycle, as well as investigate cell-cycle dependent changes in subcellular localization. 
Results were also compared to published data on gene essentiality acquired in a comparison 
between ten CRISPR/Cas9 survival screens (113). The TriComp algorithm was used to 
compare between different modes of data, and to characterize similarities and differences 
between transcriptome, proteome, and external databases. 
A total of 3355 cell-cycle oscillating proteins were identified, with the majority exhibiting an 
upregulation in either G1+S or G2, with the highest fold-change differences belonging to G2-
specific proteins. Enrichment analysis for GO-terms revealed a high enrichment for cell cycle 
processes, with many known cell-cycle regulated proteins appearing high up in the hit-list. The 
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same analysis on each TriComp group also revealed functional differences for each specific 
group. 
 
 
Figure 6. Examples of comparing transcriptional and proteomic regulation over the cell cycle 
 
When comparing transcriptomics and proteomics over the cell cycle we identified a high degree 
of correlation, either with transcripts and proteins exhibiting the exact same cell cycle 
expression pattern, or with proteins exhibiting an immediate subsequent pattern. Stratifying for 
each specific cell cycle phase revealed differences between each group of mRNA expression 
patterns. For example, G1-upregulated mRNAs mostly corresponded to G1- or G1+S-
upregulated proteins, but G2 upregulated mRNAs showed a tendency to correspond to proteins 
upregulated in the following G1 phase (Figure 6).  
Phosphatases and kinases were found to have statistically different oscillation profiles and 
phospho-events were characterized over the cell cycle through the use of TiO2 enrichment 
followed by mass spectrometry. 3317 phosphopeptides were found to oscillate over the cell 
cycle, and kinase motif recognition was utilized to describe motifs enriched for certain 
TriComp patterns. 
The proteomic analysis was also repeated but following fractionation of cellular material into 
soluble and insoluble fractions. By filtering out proteins which did not oscillate in the general 
proteomic results, but exhibited diametrically opposite patterns on the soluble and insoluble 
cell cycle, a list of 169 proteins was identified to change solubility state over the cell cycle. A 
clustered group of these was the MCM family, which was upregulated as insoluble in S-phase 
and as soluble in G1 and G2. Another protein was the S-Adenosyl-methionine donor MAT2A, 
which was upregulated in soluble G1 phase and in insoluble S and G2 phases. This was 
validated using immunofluorescence experiments to be due to a translocation from the cytosol 
to the nuclei following the G1/S checkpoint.  
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4.2 CHARACTERIZING DYSREGULATION OF THE CELL CYCLE THROUGH 
SIRNA-MEDIATED SILENCING OF THE UPS 
In Study III we developed a high-content imaging experiment using a siRNA library against 
786 genes of the UPS system, in order to characterize cellular phenotypes regarding cellular 
viability, the mitotic and regulatory cell cycle, and responses to intrinsic and extrinsic DNA 
damage. The UPS system has many confirmed and putative members, and we combined 
information about UPS genes from various databases (37,114–116) prior to designing the 
experiment. 
Four reporter systems were combined in the experiment; Fucci as a measurement of the 
regulatory cell cycle, DAPI quantification and EdU integration as an indicator of the mitotic 
cell cycle, and 53bp1-foci counting as a marker of DNA damage response to double-strand 
breaks. The study was performed at two time points and in parallel with and without external 
irradiation two hours prior to the first time point. The results showed a broad distribution of 
phenotypes among the UPS genes silenced, with an enrichment of aberrant phenotypes in the 
UPS subfamilies comprising a smaller number of genes, both on viability and on the cell cycle. 
A triangularization algorithm was used to illustrate phenotypical cell cycle results, on a three-
group categorization of either Fucci or combined data from DAPI and EdU integration 
quantification. The study was internally repeated on 20% of the initial study, and the same 
experimental setup was used on a different siRNA library comprising 78 targets, primarily E2 
family members, and on lentivirally transfected inducible shRNA cell lines, primarily targeting 
DUB family members.  
In the primary study, cell cycle phenotypes without external irradiation was primarily directed 
towards G1- or S-phase enriched phenotypes, with very few siRNA pools exhibiting a G2 
arrest. Comparing results from the two time points showed that most affected phenotypes got 
progressively worse over time, with many moving towards S-phase arrests. Almost every 
single cell cycle phenotype was accompanied by a corresponding effect on cellular viability. 
Through analyzing effects of external irradiation, it was discovered that the percentage of G2 
cell cycle arrest phenotypes was significantly higher. Arrow graphs comparing cell cycle 
phenotypes with and without irradiation revealed many of the siRNA pools causing G2 arrests 
to either not exhibit any cell cycle phenotype without irradiation, or to exhibit G1- or S-phase 
enrichments.  
The response to DSBs was investigated in the same experiment via 53bp1-foci formation 
counting, and four categories of phenotypes were detailed using data from all experimental 
conditions; spontaneous foci formation (early or late), a diminished response to DNA damage, 
and a normal response but unresolved foci at the latest time point. These four categories were 
investigated regarding cell cycle effects at all experimental conditions, and two major 
significant patterns emerged. First, spontaneous foci formation, especially at the early time-
point, was often accompanied with cell cycle enrichments towards G1/S-phase. Secondly, a 
lack of recruitment of 53bp1was often accompanied by a shift in cell cycle arrest patterns, from 
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no phenotype or G1/S-enriched phenotypes without irradiation towards G2-phase arrests when 
irradiated.  
4.3 BTBD1 SILENCING AFFECTS CELL CYCLE AND DNA DAMAGE REPAIR 
PATHWAYS, AND IS ESSENTIAL FOR TOP1 FUNCTION 
The E3 adapter BTBD1 was discovered in the initial experiment of Study III to be involved 
in viability, cell cycle and DDR response. Without irradiation, silencing of BTBD1 caused a 
G1/S-phase enrichment of cells, and combined with irradiation this was converted to a G2-
enrichment. This was additionally confirmed using an inducible shRNA cell line targeting 
BTBD1. Additionally, recruitment of 53bp1 upon DNA damage was severely reduced upon 
silencing of BTBD1, both using siRNA and shRNA, and the ability to perform DNA replication 
was impaired as measured using DNA fiber experiments.  
A phosphoproteomic experiment on BTBD1-silenced cells revealed a profile similar to that of 
external DNA damage, except for a decrease in phosphorylation of 53bp1. Investigating 
synergistic effects of BTBD1 silencing with a small chemical library revealed sensitivity to 
many cell cycle inhibitors but also insensitivity to chemicals related to DNA, such as the 
compound Camptothecin (CPT), an inhibitor of TOP1, a protein releasing DNA torsional stress 
during replication and transcription, that BTBD1 has previously been found to interact with 
(117). A chromatin-immunoprecipitation study of shBTBD1 cells revealed global arrests of 
TOP1 on transcription start sites, results that were removed upon the co-incubation with CPT. 
TOP1 was found to be reduced in western blot lysates similarly and synergistically with CPT 
and shBTBD1, independent of ubiquitin-dependent degradation. 
4.4 DEVELOPMENT OF A MULTI-FUNCTIONAL MULTI-FLUORESCENT 
PLASMID SYSTEM FOR GENETIC ENGINEERING 
Study IV describes the design and development of a multi-purpose genetic engineering system 
and show proof of concept results for the various integrated features. We also validate and 
characterize two ubiquitin E3 adaptors, ARIH1 and ARIH2, as important for Glioblastoma 
Multiforme development. 
The vector system introduced is comprised of four different kinds of vectors; silencing vectors, 
pENTR preparatory cloning vectors, constitutive pDEST expression vectors, and inducible 
pDEST expression vectors. The gRNA/shRNA-compatible gene silencing vector is ready-to-
use and lentivirally compatible. The overexpression system utilizes Gateway Cloning, where 
expression products can be modified in a small pENTR vector flanked by two attL-sites, and 
later recombined using LR Clonase between two attR-sites in a pDEST vector, which is 
lentivirally compatible and expression-ready. This allows for a flexible cloning approach, as a 
gene product can be cloned in the pENTR vector, subcloned to be tagged with different reporter 
proteins, and then Gateway cloned into different destination vectors for different purposes. 
There is a large amount of available destination vectors compatible with our system for various 
purposes, such as recombinant protein production in different species, overexpression for co-
immunoprecipitation studies, or for mapping localization within the cell (118). 
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Our vector system has a number of reporters, protein tags, selection markers, and other features, 
and a central part of the cloning design is ease of integration of the same reporter into the 
various systems. For example, a fluorescent protein can be used as a reporter of successful 
gRNA integration, a N- or C-terminal tag in an pENTR vector, or as a reporter in a destination 
vector. As similar restriction digestion sites are utilized in the different vectors, the integration 
of a new feature is easy and efficient.   
Fourteen different fluorescent markers are already integrated in the system spanning a wide 
range of the visual spectra. This allows for a high degree of flexibility in combining fluorescent 
markers depending on experimental direction or limitations in microscopes available. Having 
a large array of colors to choose from enables a high flexibility in choosing fluorescent markers 
for flow cytometry and immunofluorescence experiments.   
The system was utilized to investigate the role of two E3 ubiquitin ligases, ARIH1 and ARIH2, 
on cell cycle and viability. Using multi-fluorescent experiments, they were identified to be 
essential for cellular proliferation in various GBM cell lines and stem cells. 
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5 DISCUSSION 
5.1 THESIS FINDINGS 
5.1.1 The Cell Cycle’s Effect on Transcription, Protein Availability, and 
Protein Function. 
In Study I, (119), the comparison of transcriptional cell cycle regulation between two 
commonly used cell lines revealed a high degree of correlation, not only to each other, but to 
previous studies and to previously identified cell cycle-regulated processes. This emphasizes 
the importance of cell cycle integrity, and validates the use of cell lines as biological models of 
the cell cycle. While U2OS and HeLa cells do not actively differentiate into specific post-
mitotic cells and are quite homogenous, it was interesting to see that different differentiation 
and developmental programs could still be seen using after gene ontology enrichment analysis 
for cell-type-unique transcription factors. The specific GO-terms identified for each cell type 
related to differentiation and developmental are most likely of lesser importance as many 
transcription factors can be involved in multiple cellular programs. It is natural that the cells’ 
different heritage could still be shown in the cell-cycle oscillating transcriptional control of 
these cells.  
Other transcriptional networks were found to be oscillating in synchrony with the cell cycle, 
many with previously identified cell cycle-dependent functions, such as transcription factors 
like E2F1 (120–122), PAX6 (123–125), Notch signaling (126), WNT/Frizzled (127,128) and 
the circadian clock (129–132). The circadian clock is additionally known to regulate some of 
these factors (124,133,134) and has previously been shown to by synchronized with the cell 
cycle in in vitro cell lines (129,130). As these processes was found to be synchronized to the 
cell cycle in cell line models, this opens up the possibility of other cell-cycle processes being 
controlled by either the cell cycle directly or by these systems. A limitation of observational 
studies is drawing conclusions about cause and effect, and unraveling regulation patterns of 
closely synchronized systems requires targeted research. TriComp proved useful when 
analyzing distributions of known E2F targets to define a temporal compartment of E2F 
function, as the relationship between a transcription factor and its targets can introduce a 
pseudo-temporal method of analysis. 
Comparably to the transcriptomic analysis, a proteomic analysis of the cell cycle in Study II, 
(135), confirmed many known cell cycle regulated proteins and corresponded well with GO-
terms regarding cell cycle, while providing thousands of significant cell-cycle regulated 
proteins. Some novel proteins not GO-annotated such as AHRGAP11A, KIAA0101 and TK, 
had previously been implicated as being involved in cell cycle functions (136), or being 
degraded in a cell-cycle dependent manner (137,138), but many proteins identified had not 
previously been implicated in cell cycle biology. Interestingly, GO-terms associated with the 
cell cycle was more prevalent in S+G2 or G2-upregulated patterns, while G1- and G1+S-
upregulated patterns were mostly comprised of previously non-GO-annotated proteins. This 
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could possibly be due to the G1 phase being a preparatory gap phase. As a majority of cell 
cycle physical changes happening in S-phase and mitosis, an enrichment in GO-cell-cycle-
terms for proteins interacting with these later phases is natural. Still, it is interesting that many 
proteins do exhibit an upregulation in G1-phase, and enrichment analysis revealed many G1-
upregulated proteins to be involved in ribosome biogenesis, a preparatory function for building 
up cellular material.  
Gene ontology enrichment analysis on each different TriComp pattern was useful in defining 
temporal compartments for different processes. Many processes were unsurprising, such as the 
fact that “DNA replication”-annotated proteins were upregulated in S-phase (although proteins 
even carried over into G2-phase). Interestingly, the two different groups of G2-upregulated and 
G2+G1-upregulated proteins revealed a difference in GO-terms, where “Mitotic Nuclear 
Division” preceded “Chromosome Separation”. Proteins involved in chromatin separation 
would take longer to be removed than proteins involved earlier in the mitotic process, thus 
explaining their presence in the following G1-phase. 
Comparing mRNA and protein oscillations revealed mRNA fluctuations translated to either a 
similar pattern on protein levels or one TriComp group forward. A TriComp analysis of 
relationships (instead of estimating the time-point of maximum expression) was useful here in 
order to separate proteins upregulated through a single phase from proteins upregulated and 
remaining elevated into the next phase. Aside from transcriptional regulation which is reflected 
in the mRNA oscillation patterns, the turnover time of the proteins through stability and 
degradation affects the protein levels in a specific cell cycle phase and the combined knowledge 
of mRNA and protein oscillation patterns can hopefully be useful as a resource. The results 
also highlight the complexity of dynamics between transcriptional regulation, protein 
expression and stabilization of protein levels in the cell (14). 
The conversion of transcriptional regulation to protein level changes is not instantaneous and 
results regarding G2-specific mRNAs corresponding to G1-upregulated proteins might 
highlight a preparatory function of the cell prior to mitosis to prepare for functional needs of 
the daughter cells. During the phases of mitosis when chromatin is condensed transcription is 
not possible (139), delaying the production of G1-specific proteins further unless prepared for 
prior to mitosis. 
Phospho-proteomic and translocation results from Study II in combination with earlier results 
strengthens the resource aspect of the work, and the translocation-finding algorithm of 
identifying diametrically opposite cell-cycle oscillation patterns in soluble and insoluble 
oscillating proteins proved a useful method of identifying proteins changing subcellular 
localization in response to cell cycle events. Proteins exhibiting differences in soluble and 
insoluble cell cycle expression could be explained either as a solubility change of larger cellular 
structures, a solubility change of a protein and its interaction partners, or a translocation 
between two cellular compartments. Examples of all three reasons were identified, as traces of 
mitochondrial fission events (140–142) could be seen in the soluble fraction in S-phase, the 
stabilization of MCM proteins on DNA to enable replication during S-phase (143), and the 
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translocation of MAT2A from cytosol to nucleus to act as a methyl donor for the cells’ 
increased methyl needs in S and G2 phases (144–146). 
Most hit lists from Study II were enriched for essential genes for cellular proliferation, based 
on comparison with CRISPR/Cas9 survival screening studies (113). This enrichment highlights 
the link between essentiality of function and expenditure of regulation, as a gene coding for a 
protein with an integral function is more likely to be regulated. The two most integral functions 
for a cell is unhindered progression through DNA replication and mitosis, and maintaining 
integrity of the DNA, and these processes has changing needs throughout the cell cycle.  
5.1.2 Characterizing Effects of the Ubiquitin Proteasome System on Cellular 
Viability, the Cell Cycle and the DNA Damage Response 
The characterization of the gene-per-gene silencing of the ubiquitin proteasome system in 
Study III revealed a wide and complex array of phenotypes, highlighting the large amount of 
protein and cellular processes in which the ubiquitin system is present, both in a regulatory 
capacity and through degradation of unwanted proteins. Differences in subfamily phenotype 
distributions were identified; E1 enzymes, E2 conjugating enzymes, and deubiquitinating 
enzymes were enriched for phenotypes compared to E3 ligases and E3 adaptors, both regarding 
viability and cell cycle. The lower prevalence in phenotypes in E3 family members can be 
explained by them having many specific roles, many which utilizes the same E1 and E2 
enzymes. It is likely that many of these E3-mediated processes are not required in the U2OS 
cell line or being used for higher-order functions such as cellular organization or tissue- and 
organ-specific functions. This would explain the lower prevalence of viability phenotypes in 
this ubiquitin subfamily.  
The combined phenotypical results from different reporter systems, from different time-points, 
and with external irradiation, were utilized together to elucidate effects of each specific siRNA-
based silencing of a UPS-related gene. The combination of regulatory cell cycle data with 
mitotic cell cycle data adds more information when describing a dysregulation into the cell 
cycle. Using a triangularization method of visualizing the results on cell cycle, the effects could 
also be compared over time and after irradiation. This revealed that most cell cycle phenotypes 
enriched for a specific phase are intensified from the first to the second time point, also 
correlating with viability. 
Silencing of UPS genes exhibited various cellular phenotypes, primarily enriched towards G1-
phase or S-phase. Upon external irradiation however, many G2-enriched phenotypes appeared, 
many from proteins previously not having a phenotype. The difference in these phenotypes 
could be due to synthetic lethality, where two events which the cell is capable of handling 
together becomes unmanageable. The UPS proteins exhibiting these phenotypes could be 
involved in a process where the cell has redundancy, or is able to deal with the consequences 
without stopping cellular proliferation. For a protein involved in DDR or maintenance of DNA 
integrity, the addition of a secondary problem, such as external irradiation, could overwhelm 
the repair machinery and lead to an inability to progress through mitosis. The cell has many 
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processes involved in handling unexpected problems, especially DDR, and an external trigger 
of problems might be required to reveal an inability to respond. Study III also revealed that 
when silencing UPS genes resulted in a decrease in 53BP1 recruitment to DSB sites upon 
irradiation, the cell cycle phenotype the following day was more often a G2-phase arrest. This 
supports the argument that removing proteins essential for DDR could synergize with 
irradiation to create a cell cycle arrest.  
The combination of reporters for viability, cell cycle and DDR response in the same high-
content experiment allowed for summarizing and comparing results both regarding specific 
genes, but also allowed comparing how dysregulation of cellular processes correlate and 
interact to each other, using the UPS genes as a snapshot of the human genome. 
5.1.3 The Role of BTBD1 in TOP1 Function, Cell Cycle Progression, and DSB 
Repair 
In Study III, siRNA-based silencing of the E3 adapter BTBD1 exhibited a plethora of 
phenotypes. It changed cell-cycle enrichment phenotypes upon irradiation, and had one of the 
highest effects on reducing 53BP1 recruitment to DSB sites. This was additionally confirmed 
with shRNA-based studies and the HR/NHEJ imbalance was studied further with 
immunofluorescence and phospho-proteomic experiments. BTBD1 was previously known to 
interact with TOP1 (30,117), confirmed through a proximity ligation assay and was also found 
to arrest TOP1 at transcriptional start sites and reduce available TOP1 in western blot lysates 
similarly to CPT. This points to BTBD1 having an essential role for TOP1 function, although 
not through ubiquitin-mediated degradation as TOP1 reduction persisted even with the 
inclusion of MG132. 
CPT is used clinically in cancer therapy, and stabilizes TOP1 covalently bound to DNA during 
the time the DNA unwinds (147). While CPT mimicked the effects of BTBD1 silencing, it did 
not cause the same pattern of TOP1 arrest at TSS identified through ChIP. This might be due 
to differences in dynamics. While CPT has a more extreme effect on replication, it is not itself 
covalently bound to TOP1. As TOP1 is involved to release torsional stress in DNA during 
replication, transcription, and possibly DNA repair (148–151), the effect of BTBD1 silencing 
on TOP1 could help explain the various phenotypes on the cell cycle and DSB repair choice 
observed upon BTBD1 silencing.  
5.2 METHODOLOGICAL CONSIDERATIONS 
5.2.1 Advantages and Disadvantages of Cell Line Models 
This thesis relies primarily on results from in vitro immortalized cell line culturing. Laboratory 
cell lines are advantageous in that their growth is consistent and experimental results are 
therefore highly reproducible. As the cells belong to a homogenous population, other basic 
cellular systems are also consistent and reproducible, such as responses to DNA damage, 
replication, and transcription regulation. Other advantages to cell line studies is the ease and 
flexibility of use compared to tissue or animal models. On a molecular and intra-cellular level, 
  29 
cell line research is thus a highly advantageous flexible model system to study protein and 
cellular biology. 
The trade-off is limitations in translation to higher-level functions, such as tissue-level spatial 
organizations and signaling, and organ- and organism-level functionalities. A caveat that is 
always present in high-throughput or omics- cell line studies is that an unknown percentage of 
studied genes and proteins could have functions of higher orders that are not reflected in the 
model, or have a cell-type specific function in a cell type other than the one studied. In Study 
I, unique HeLa and U2OS cell-cycle regulated transcripts were enriched for developmental 
GO-Terms, reflecting their difference in tissue origin. Often, transcripts or proteins without a 
cell-type specific function might not be detected due to low expression, but they could still be 
detected and even found significantly oscillating due to co-regulation, intended or unintended. 
Although genomic analysis can be used to study co-localized genes in the same chromosomal 
vicinity and separate primary expression results to passenger results, spatial co-localization 
from different genomic loci can also play a role in gene regulation (152). In Study III, the 
lower prevalence of cellular phenotypes upon silencing E3 ubiquitin ligases and adapters can 
also be explained by many of these having possible functions not necessarily needed in a 
biological cell line model. As different E3 proteins utilize the same E1 and E2 proteins, this 
explains the latter’s higher prevalence of phenotypes when removing these multi-functional 
family members. While not in the scope of this thesis, integration of analysis tools on genomic 
localization and spatial chromosomal localization could prove advantageous to further 
elucidate the interplay between genes and to identify co-regulated networks. 
5.2.2 Studying the Cell Cycle – A Comparison of Methodologies 
Studying the cell cycle can either be performed through synchronization of cells and 
performing an experiment in the time-frame before the cells desynchronize, or with exogenous 
reporter systems. In this thesis, two methods were utilized to study the cell cycle in 
asynchronous cells; the regulatory Fucci reporter system and a combination of the chemicals 
DAPI and EdU to describe the mitotic cell cycle by measuring chromatin content and 
chromatin replication. In Study I, cell-cycle transcriptional oscillation patterns from 
asynchronous Fucci cells were compared to published data from synchronized cells (10), with 
a high degree of correlation, although the information procured differed as the TriComp 
algorithm provided a measure of relationship between three groups. 
Fucci as a reporter system provides information on the SCF/APC-complex balance in the 
regulation of the cell cycle, while DAPI and EdU reports on the physical stage of DNA 
replication. During the unperturbed cell cycle the reporter systems correlate highly, but when 
disturbing the cell cycle, the systems can differ. This can be advantageous in elucidating the 
state of the cell, and to infer possible reasons for cell cycle arrest. Fucci and DAPI/EdU can 
thus complement each other and the combined information can give a detailed description of 
cell cycle state.  
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A limitation of using Fucci or DAPI/EdU methodologies is the need for categorization of 
stages. In a synchronization experiments, cells can be followed up at certain time-points, a 
quantitative variable, and the temporal resolution will depend on the methodology and specific 
biological question. When studying asynchronous cells using either Fucci or DAPI/EdU data, 
a categorization of cell cycle phases is required, and this requires different strategies in 
downstream analysis.  
5.2.3 A Comparison of Gene Silencing Methodologies 
Throughout the studies, different methods of gene silencing were utilized; siRNA libraries, 
inducible shRNA vector constructs, and single-site targeted CRISPR/Cas9. The choice of gene 
silencing system depends on the specific use case, and weighing the downside of immediate 
stress to the target organism versus ease of use, consistency and efficacy. 
siRNA libraries are easy to use and scale up to higher throughput. The major downside to 
siRNA-mediated silencing is its time-dependency, and possible variance between experiments. 
Stably transduced inducible shRNA constructs on the other hand, separates the immediate 
stress of viral delivery and genetic insertion from the actual experiment. Successfully integrated 
cells can be selected using antibiotic selection or through flow cytometry with a fluorescent 
reporter. After cells have recovered from the lentiviral-mediated integration, cells can be frozen 
down in homogenous vials, and experiments can be performed again and again with minimal 
variance arising from the integration method itself. Additionally, due to the shRNA being 
induced by doxycycline, the same cell line can be used as a negative control, without induction 
of shRNA, further limiting technical variance. The downside of shRNA silencing constructs is 
the time and effort in producing individual shRNA plasmids and producing lentivirally 
integrated cell lines, although these processes can be automated to some extent. 
Both siRNA and shRNA silences genes through RISC-complex-mediated degradation of 
targeted mRNA, a process which is dynamic and reversible. This requires a continuous 
presence of siRNA or shRNA in order to keep mRNA levels low, and a possible minor leakage 
from an inducible system will have negligible effects. CRIPSR/Cas9-mediated silencing on the 
other hand is an irreversible process. In our CRISPR/Cas9-compatible plasmid system we use 
a one-site target, often targeted to the first exon of a mRNA, that when damaged and repaired 
via NHEJ leads to the loss of a small number of basepairs and a frameshift of the mRNA 
sequence. Because it is irreversible, a small leakage of an inducible system would inevitably 
lead to a buildup of edited cells, provided the mutation is not lethal or affecting cellular growth. 
Therefore, our system combines an inducible Cas9 protein with inducible gRNA expression, 
to minimize this risk logarithmically. 
5.2.4 Why Flexibility is an Important Feature of a Plasmid System 
In a modern biology or biomedical laboratory, genetic manipulation of biological models is 
performed routinely, either via small fragments of DNA such as siRNA using chemical vectors, 
or in more stable systems such as viral delivery of new genetic material for either transient 
expression or stable integration in the cell’s DNA. There are hundreds of available commercial 
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and non-commercial genetic vectors for these purposes, and many laboratories use many 
different systems.  
In a biology or life science research setting, experimental designs are often prone to change 
due to unforeseen challenges and development of novel techniques. Throughout the life of a 
project, new experiments may be needed and results may necessitate the inclusion of 
experiments and tools not originally thought needed. In this dynamic setting, a flexible genetic 
engineering system can prove useful. Genetic tools developed for an experiment can be 
repurposed for another if the genetic vector system allows. This is the design principle of the 
vector system described in Study IV. Aside from a quick, modular and efficient way to move 
genetic codes for expression or downregulation to new vectors, the system also allows for rapid 
integration of new reporters and selection markers.  
Utilizing a suite of fluorescent proteins over the entire range of visible light not only allows for 
a range of choices and combinations with reporter systems, but also multiplexing. Different 
genetic sequences can be experimentally combined after being subcloned into vectors with 
different fluorescent reporters, which allows for a high throughput and a higher degree of 
internal control in multi-fluorescent experiments 
The plasmid system and laboratory predecessors described in Study IV has already been 
utilized by various laboratories, and while many collaborations are still ongoing, some have 
already resulted in published scientific articles (153–156) . 
5.2.5 Designing a High Content Imaging Experiment – A Matter of Scale 
Although the initial figures of Paper III describe results from a high-content imaging 
experiment comprised of ~16 000 multiplate wells, it is important to note that the experiment 
was not performed without prior optimization, both of individual reporter systems but also in 
the process of scaling up from smaller to higher throughput. Designing an experiment 
immediately on the highest throughput will undoubtedly lead to unforeseen problems and it is 
important to be aware of the necessity of pilot studies and optimization procedures. Thus, I 
wanted to briefly describe the process of the main experiment in Study III from the point of 
view from the design of the experiment, focusing on the path from initial experimental design 
to concluded experiment (Figure 7). 
The initial experimental design was to combine four reporter systems in one experiment; Fucci, 
DAPI, EdU integration, and antibodies against 53bp1. Additionally, the experiment would be 
performed with two separate time points, and one set of the experiment would be irradiated 
prior to the first time point. Practically, each reporter system first had to be tested and optimized 
one by one in a plate format. Since the red and green fluorescent channel was already occupied 
by the integrated Fucci system, infrared and blue channels had to be utilized for EdU and 53bp1 
reporters. As DAPI staining would be more than a hundred-fold higher intensity than an alexa-
405-conjugated secondary antibody, it was decided to utilize the blue channel twice, first for 
the antibody and then after imaging restained with DAPI and imaged again. An alignment 
algorithm was used to merge the resulting images. 
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Figure 7. Design and optimization of a high-content experiment. 
 
After all reporter systems were optimized and a protocol determined, we performed a pilot 
study on a series of chemicals with known cell cycle effects. During these trials it was 
discovered that the click-chemistry reaction (specifically, the cupric 2+ ions) had a quenching 
effect on the fluorescent proteins of the Fucci system. Fortunately, this quenching is reversible 
(157) and as the protocol continued with antibody incubations and a series of washes, the cupric 
ions were removed and fluorescence restored before final imaging. 
After multiple test trials in 96-well format, including the addition of multiple time-points and 
external irradiation, the last optimization required scaling up to high-throughput 384-well 
format. This process focused on pre-emptively solving problems of scale. Scaling problems 
can be divided in timing and practical matters. Each handling of a plate takes a certain amount 
of time and it is easy to underestimate the combined handing times even for a simple washing 
step, possibly leading to differences in plate handling and unwanted addition of variance. Batch 
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sizes for each experimental procedure needed to be determined according to determined 
bottlenecks, and staggering steps introduced to the protocol to avoid downstream timing issues. 
Practical problems of scale can be related to the small volumes and well sizes of the experiment. 
With smaller volumes, any variance in addition or removal of liquid can be a problem, and the 
consistency of plate aspirators needed to be measured, especially for small-volume removals 
such as antibody incubations. Foam is also a much larger problem in 384-well formats, and 
steps with detergent present might necessitate inclusion of a foam-removal step, such as gently 
dabbing the plate on a fiber-free tissue.  
Even after an experiment is finished and all images are acquired, batch- or plate-specific effects 
can still appear and it is thus important to add enough negative controls for normalization after 
the experiment is finished. The addition of negative controls spread out over the plate can help 
identify sources of variance and aids in determining normalization procedures. When deciding 
on how controls can be included, it can be advantageous to wait until test trials are at the final 
scale, as scaling could reveal new methodological issues to control for. Different studies might 
necessitate different control distributions, be they a single column per plate, a semi-random 
placement over the plate, or a plate-per-plate randomization.  
Image and data analysis after images are acquired normally follow the same iteration of 
developing analysis method for a specific feature, normalizing for any batch-wise or plate-wise 
effects, then designing a final analysis pipeline for use on the entire set. In order to keep this 
process objective and structured, it is advantageous to include chemical controls with known 
phenotypes in an image analysis study, as these control images can be utilized for development 
of the image and data analysis pipelines. 
5.2.6 Data Analysis of High Content Imaging Data – a Structured Approach 
Compared to Computer-Assisted Methods 
In modern medium and big data analysis pipelines, machine-assisted classifications are often 
utilized, either to assist or to replace defined categorical rules based on biology. While a human 
scientist can rely on their expertise in the field to draw up classification criteria, a machine can 
access a massive amount of information to guide classifications. Computer-assisted 
classifications has many advantages but lacks the intuition and experience of human scientists. 
It is a part of human psychology to insert new knowledge into older contexts, and while this 
can be perilous by risking confirmation bias or through overconfidence, it can be valuable to 
analyze biological and life science data in the context of prior biological knowledge. The 
utilization of intuition is dependent on objective expertise (158), and while it requires rigorous 
statistical tools to avoid confirmation biases, can be valuable in directing research. 
During image analysis, especially in a high-content study, it is easy to generate an 
overwhelming amount of information, with many pieces of information being redundant to 
each other. When extracting feature descriptors in an image analysis pipeline, hundreds of 
features can easily be acquired from a simple experiment. Depending on the choice of analysis 
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method, be it based on strict biological criteria or through machine-learning-assisted classifiers, 
feature extraction from image data will inevitably vary. 
For example, the question: “How bright is this cell”, can be answered either with the average 
pixel intensity, the integrated pixel intensity, the maximum pixel intensity, the average of the 
brightest 25% of pixels, or with even more advanced feature descriptors. Although many of 
these answers are highly correlated to each other, the choice of descriptor depends on the 
behavior of the reporter, background noise, prior segmentation problems, and the biological 
question. In the main siRNA experiment in Study III this is highlighted where the chemical 
EdU is measured with average intensity, the chromatin quantification measured with integrated 
intensity, and the two Fucci colors measured with upper quartile intensities. The choice was 
guided based on pilot analyses and biological interpretation, in order to choose the feature 
descriptor most likely to correspond to the biological question without being affected by 
methodological problems.  
An alternative approach is to extract all possible information and use a machine learning tool 
to analyze and categorize cells. For human-assisted analysis, the inclusion of hundreds of 
variables can be confusing, but a computer has a larger accessible memory. If many of the 
features are highly correlated, a machine learning approach will have no problem taking this 
into account, and the combined information can sometimes be more valuable than a 
strategically chosen individual variable. In the validation of MAT2A’s cell-cycle dependent 
localization changes in Study II, we utilized the Classifier tool from CellProfiler Analyst (159) 
using all fluorescent feature descriptors from the segmentation of cytosol and nuclei to identify 
a cell-cycle dependent shift in localization.  
The coming decades will be challenging in combining information from human and machine 
classifiers, and if done correctly, could combine the advantages of both while avoiding the 
pitfalls of each.  
5.2.7 A Novel Use of Dimensionality Reduction for Visualization of Three-
Dimensional Data.  
In Study I, II, and III, the aims and biological questions necessitated the development of novel 
methodologies for visualization and comparison of high-dimensional data. In Study I and II, 
a polar coordinate system was utilized to visualize the cell cycle expression of transcripts and 
proteins respectively, and in Study III the distribution between three cell cycle phases is 
reduced to a two-dimensional representation of the data without loss of information. 
For expression data, the variable “logarithmic expression” is a quantitative variable with no 
bounds or limits. The fold change difference between two groups belong to the same variable 
type, there are no maximum fold change differences. On the other hand, when comparing three 
distribution variables, both the prevalence of a specific type of cell and the difference between 
two prevalences are also ratio quantitative values, but these are finite in both directions, and 
cannot be smaller than 0% or higher than 100%. Aside from the difference in statistical 
approaches when analyzing these two variables, visualization also requires different strategies. 
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Reducing three dimensions to two without any loss of information is axiomatically impossible. 
A preferable characteristic of an algorithm producing a visual graph is that the coordinates 
should be two-dimensional to print on paper, or shown on a computer screen. Both methods 
had to approach this challenge, albeit in different ways.  
 
 
Figure 8. Reducing dimensions for visualization of the relationship between three groups. 
 
For the polar coordinate system, we start with three variables; three measures of expression. If 
we do not mind losing the information regarding the average expression of the transcript or 
protein, if it is high- or low-expressed, we can express the relationship between the groups in 
two dimensions. The expression of the three groups can either be seen as three individual 
values, or it can be seen as an average value plus a relationship between three values (Figure 
8). Such a relationship is two-dimensional, as the information about two of the differences is 
enough to provide the third, they thus carry redundancy. When treating it as three individual 
values we don’t know which one to remove, as we deem all equally important for 
understanding the biology. But converting to polar coordinates allows us to plot the relationship 
between the three groups in two-dimensional space. An additional feature of the TriComp 
algorithm is that the two polar coordinates carry different information. The angle θ describes 
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the type of relationship and the radius r describes how intense the relationship is. This can be 
useful for comparing different experiments, by plotting θ-values against each other and filter 
on r and an accompanying p-value. The average expression was abandoned before polar 
conversion but we can still utilize the average expression later in downstream analysis for 
filtering or plotting using opacity, shape, or size, but it is superfluous in describing the 
relationship between the three groups.   
The use of the TriComp algorithm also enables a high resolution of describing a relationship 
between the three groups. The θ variable is quantitative and each value corresponds to an exact 
relationship. Two different mRNAs that are highly expressed in G2-phase might be different 
during the rest of the cell cycle, and including information about S-phase expression can 
elucidate a more informed knowledge about cell cycle oscillation patterns. While the high 
resolution of time points after synchronizing cells (10) achieves a higher temporal resolution, 
a high number of time-points makes it harder to summarize patterns of cell cycle fluctuations, 
and necessitates the use of pattern-finding algorithms.   
The triangularization algorithm summarizes three-group distribution patterns in a similar 
manner to TriComp, but an important distinction is that as the distribution of three groups is 
functionally two-dimensional if they together equal 100%, the data can directly be positioned 
in two-dimensional space (Figure 8). A triangle was chosen for symmetry, with each corner 
representing a full arrest towards that cell cycle phase. In distribution analysis, changes in 
distributions does not need logarithmic representation, and the triangular coordinate system is 
thus linear. 
When comparing two different data sets to each other, a structured approach can be 
advantageous. While modern clustering methods, such as t-sne or Principal Component 
Analysis (PCA), are accessible and easy to use in many softwares, clustering coordinates from 
t-sne or PCA is created anew for each data analysis. In order to compare results from two 
different sets of data, they would need to be employed to categorize phenotypes independently 
and then the resulting phenotypes can be compared as two categorical variables. The TriComp 
method allows for a structured approach, and the resulting quantitative variable θ was used 
throughout Study I and II when compared to external data and between TriComp datasets. 
Throughout the studies TriComp data was compared to or stratified over categorical descriptors 
such as membership of protein families of transcription factors (160), kinases (161), 
phosphatases (162), E2F targets (163) or GO Ontology terms, ordinal variables such as an 
index of essentiality (113), and quantitative data such as previously characterized cell-cycle 
fluctuations (10,11). 
The primary limitation of TriComp and the triangular visualization of distributions is that they 
are limited to three measured groups. Three expression levels can be reduced to two dimensions 
by ignoring the average value, but four or a higher amount of groups cannot. However, for 
biological questions with three natural groups, the algorithms have proved their usefulness. 
Both methods developed made it possible to summarize results at high information density, 
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categorize phenotypes, and compare results between conditions and to external data (Figure 
9). 
 
 
Figure 9. Utilizations of the TriComp and the triangularization algorithm. 
 
5.2.8 Visualization of Multi-Parametric Data Using Geometry and Color 
While paper or computer screen still images are limited to showing two dimensions, there are 
many additional ways to incorporate more dimensions in an image, such as color, opacity, 
shape, size, arrows, or integrated pie-graphs. See Figure 10 for an early choice during Study 
III in summarizing all data on siRNA-silenced UPS genes. Figure 10A combines eight 
different phenotypical variables into a single donut-donut-circle-graphic, repeated for every 
UPS phenotype and clustered with a t-sne method. Fucci cell cycle distribution is represented 
as the outer ring in red/yellow/green, chromatin content distribution in the inner in blue-scales, 
the average EdU integration as the intensity of the inner circle, and viability as the size of the 
entire graphic. T-sne was used to cluster the data, which utilized the two coordinate dimensions. 
Note that while the image contains plenty of information, its usefulness to describe the results 
can be questioned. Too high density of information can quickly risk becoming cluttered and 
unintelligible. Reducing the number of included phenotypes results in a simpler more 
informative figure (Figure 10B), which only includes Fucci cell cycle distributions displayed 
as a pie graph, with sizes corresponding to viability. This results in a graph easier to interpret, 
confirming the proverb: “Less is more”. It is possible to see that most cell cycle arrests are 
θ
r
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accompanied by a lower viability, and all siRNA pools not resulting in a phenotype are 
clustered some distance away.  
 
 
Fig 10. Three methods of clustering and visualizing cell cycle distribution phenotypes 
 
The reason Figure 10B was never included in the manuscript is because it was unable to answer 
a central scientific question of the experiment; how cell cycle phenotypes are affected by time 
and irradiation. The resulting graphic needed to be able to answer whether the induced 
phenotype when silencing a gene would change depending on time and irradiation. In order to 
actually compare the changes visually, there arose a need for a structured coordinate system, 
defined as the same x-y-position carrying the same meaning between experiments. A structured 
triangular method of visualization was thus chosen (Figure 10C), containing the same 
information as the previous t-sne graphic. Although inspired from t-sne generated clustering, 
the major advantage with the structured approach is that the same point in space corresponds 
to an exact phenotypical distribution, and a specific distance in the graph corresponding to a 
specific change in cell cycle distribution patterns. The x-y-coordinates are used both to cluster 
and to describe the data, compared to t-sne methods which needs overlaid pie graphs to 
visualize the data. The structure also plotting allows for comparison of phenotypes over time 
and irradiation, by plotting arrows onto the triangular space (Figure 11). 
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Figure 11. Comparison of cell cycle phenotypes over time and irradiation in a structured space 
 
When introducing more dimensions through the use of colors, opacities, sizes, or shapes, it is 
important to avoid information overload, and presentation of multi-dimensional data is 
pedagogically improved if the biological information is inherently reflected in the graphic 
utilized. For example, size can be an useful indicator of cellular viability. Scaling the size of a 
graphic describing a cell cycle phenotype according to the viability serves multiple functions. 
Any viability phenotypes that are essentially lethal, i.e. no surviving cells, will minimize the 
graphic, the information about cell cycle distribution is less important if most of the cells are 
already dead. Additionally, the reader of the graph can easily internalize that size is an indicator 
of the amount of cells.  
Opacity can be utilized without informational overload when filtering on statistical certainty, 
as its main effect on a graphic is hiding it, reducing its visibility. Similarly, shapes and colors 
are more appropriately used to differentiate between groups or subdivisions of data, perhaps to 
showcase differences or highlight a categorization based on a quantitative variable. Arrows are 
a useful graphical tool when visualizing paired data, although focus will inevitably be drawn 
to the longest arrows, making them useful when a change in coordinates correspond to shifts 
in searched for results.  
A majority of the graphics produced throughout the studies comprising this thesis were 
produced with ggplot2 (98), a package for the programming software R built under the design 
principle of enabling a “grammar of graphics”, compared to most graph softwares’ template-
based designs. When designing custom visualization methods including the tools described 
above, ggplot2 is heavily recommended by the author. 
Population Enriched
for G1 cells
Enriched for
G2 cells
Enriched for S
phase cells
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6 CONCLUDING REMARKS 
Essential biological functions are often complex, and the cell cycle, DDR, and the UPS are no 
exception. Throughout this thesis, regulation and dysregulation of and by these processes were 
characterized and summarized. The cell cycle was found to affect a large amount of the cells’ 
mRNA and protein, as well as functional processes such as phosphorylation and subcellular 
localizations. The UPS was functionally characterized regarding basic cellular processes, and 
a wide variety of phenotypes were established, mirroring the complexity of the family with 
over a thousand associated members.  
Aside from providing results in resource formats, the studies also investigated novel roles of 
proteins regarding these processes. MAT2A was identified to change subcellular localization 
over the cell cycle, ARIH1 and ARIH2 were identified to be essential for GBM growth and 
proliferation, and the E3 adapter BTBD1 was found to be essential for viability, normal cell 
cycle progression, and a functional NHEJ-response to DNA double-strand breaks. 
Investigating the role of BTBD1 further, it was discovered to mirror certain aspects of the 
cytostatic drug Camptothecin and arrest TOP1 bound to DNA. 
Both TriComp and the triangularization algorithm employed in these studies were developed 
in response to scientific questions which standard methodologies failed to answer. While there 
exists a multitude of methods of clustering and categorizing phenotypical data, a structured 
approach is advantageous to be able to compare results and link the presentation of data directly 
to biological information. By utilizing novel approaches in dimension transformation and 
selection of dimensions, a structured approach was enabled throughout the studies. Two 
distinct but similar algorithms were utilized to visualize, categorize, and compare mid-
dimensional data in an informative manner. Although modern computer-assisted classifiers 
have no need for visualization, and can effortlessly juggle thousands of dimensions, the 
utilization of the expertise and intuition of human scientists requires presentation and visual 
inspection when presenting and analyzing biological and life science data. Humans are experts 
at finding patterns and correlating disparate pieces of information, but at higher complexities 
of information we struggle. I believe an efficient approach in high-throughput and high-content 
analysis is to reduce information overload through the use of structured approaches of 
dimensionality reduction where the biological information is visible in the final variables, 
combined with sound statistics and scientific methodology. 
In this thesis, observational studies of the cycle transcriptomics and proteomics are combined 
with a systematic characterization of phenotypes of cellular processes upon removal of UPS 
proteins through genetic interference. By studying both the intrinsic regulation of and by the 
cell cycle through observational studies, and the dysregulation through the functional removal 
of essential proteins, an enhanced understanding of basic cellular processes can be acquired, as 
well as identifying novel protein candidates involved in critical intra-cellular processes. 
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7 POPULAR SCIENCE SUMMARY 
Our bodies are built out of tiny compartments called cells, each with a different role to play to 
support its larger body, the organism. Every function in the organism is on a microscopic level 
carried out by these cells, and the process through which the cells multiply and grow is called 
The Cell Cycle, which is divided into distinct and carefully orchestrated phases: 
A cell is born. 
A cell waits for a signal 
A cell copies its genetic material. 
A cell grows and prepares to split into two. 
A cell divides and becomes two daughter cells. 
A cell is born                                       A cell is born. 
Start 
G1 Phase 
S Phase 
G2 Phase 
Mitosis 
Restart
Inside the cell, three sets of molecules act together to control its functions. They are called 
DNA, mRNA and proteins. DNA is in charge of planning, and all its schematics have been 
inherited from previous generations. DNA is also a large molecule in need of protection from 
outside damage, and does not want to move far from its compartment in the middle of the cell. 
When the cell requires a specific schematic for execution, it copies its plan to mRNA molecules 
for transport to the building sites. At the building sites the proteins are being built according to 
the plans. Proteins are the molecules with “the real jobs” in the cell and each protein is built for 
a specific function; cutting things apart, gluing things back together, moving things back and 
forth, operating signals to other proteins, and some even take out the trash and clean up the cell.  
This last group of proteins is quite interesting, as they are often thought to only discard 
unwanted proteins, or proteins that are old and degraded. In reality, there are over a thousand 
different versions of these proteins, and they use a quite complicated labeling system, where 
much of the labeling still has unknown purposes. The labeling uses a simple tag, called 
ubiquitin, which can be applied in many different ways with different meanings. The entire 
group of proteins are named based on their labeling system, and they are called “The Ubiquitin 
Proteasome System”. It is now known that this labeling can be used for much more than just 
taking out the trash, and these proteins have been shown important for many processes in the 
cell, including control of the cell cycle and repair of DNA. 
This thesis investigates the interplay between the RNA runners and the Protein workers 
(especially the ones taking out the trash), all in the context of the cell cycle and DNA repair. It 
further investigates how the cells’ requirements change throughout the cell cycle and how the 
different systems rely on and affect each other. 
In Study I, the RNA is investigated throughout the cell cycle, and a specific group of proteins 
in charge of deciding when the RNAs are created are focused upon. 
 44 
In Study II, the focus shifts to the proteins, and investigates how the changes on RNA 
investigated in Study I translates to changes in proteins during the cell cycle. Protein functions 
are also investigated through the study of their modifications and where in the cell they are 
located. 
In Study III the different kinds of ubiquitin-labeling proteins are studied by removing them 
one by one and investigating effects on the cell cycle, as well as on other basic processes in the 
cell. This is done by taking millions of photographs of cells, and letting a computer analyze 
each cell. With enough cells photographed, we can describe exactly where the cells are in the 
cell cycle and see which proteins were necessary for normal progression.  
Study IV describes a laboratory system of manipulating the DNA in order to affect the amounts 
of RNA and proteins in the cell. This system can be used to study many different questions in 
biomedicine and biology, including evaluating two ubiquitin-labeling proteins on their effect 
on growth and cell cycle progression in multiple cell lines of glioblastoma multiforme, an 
aggressive form of brain cancer. 
Throughout the studies, large and complex amounts of data were generated. Novel methods in 
visualization were developed and used to describe and analyze the resulting data. A common 
design principle of these methods aimed to pedagogically describe complex data through the 
use of geometry and colors, with the final visualized data reflecting the biology studied in the 
projects. This was used throughout the studies in order to distill meaningful information from 
complex data, which could be used to identify novel genes and proteins involved in basic 
cellular processes. 
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